You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Retinoic%20Acid%20Receptor%20Alpha%20(RARA)%20positive

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

MDS Trial in Worldwide (Tamibarotene + Azacitidine, Tamibarotene Matched Placebo + Azacitidine)

Recruiting
  • Myelodysplastic Syndromes
  • Tamibarotene + Azacitidine
  • Tamibarotene Matched Placebo + Azacitidine
  • Tucson, Arizona
  • +87 more
Feb 2, 2023

Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in France, United States (SY-1425 (tamibarotene), azacitidine,

Active, not recruiting
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndrome
  • SY-1425 (tamibarotene)
  • +2 more
  • Hartford, Connecticut
  • +25 more
May 4, 2022

Acute Promyelocytic Leukemia, Induction Therapy, Oral Trial in Beijing (Etoposide, Daunorubicin)

Recruiting
  • Acute Promyelocytic Leukemia
  • +2 more
  • Beijing, Beijing, China
    Peking University Institute of Hematology
Apr 26, 2023

BRCA1 Gene Mutation, BRCA2 Gene Mutation, Folate Receptor Alpha Positive Trial in Columbus (other, biological, drug)

Active, not recruiting
  • BRCA1 Gene Mutation
  • +9 more
  • Laboratory Biomarker Analysis
  • +3 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Sep 16, 2022

Acute Myeloid Leukemia Trial in United States (Tamibarotene, Venetoclax, Azacitidine)

Recruiting
  • Acute Myeloid Leukemia
  • Duarte, California
  • +7 more
Mar 27, 2022

Depressive Disorder, Major, Bipolar Disorder, Post Traumatic Stress Disorder Trial in New Haven (Ketamine, Perampanel, Placebo)

Not yet recruiting
  • Depressive Disorder, Major
  • +2 more
  • New Haven, Connecticut
    Yale University
Jun 26, 2023

APL Trial in Shanghai (Chidamide+venetoclax)

Active, not recruiting
  • APL
  • Shanghai, Shanghai, China
    Jiong HU
May 30, 2023

CBFA2T3-GLIS2-positive Acute Myeloid Leukemia, AML, Childhood, Relapsed Pediatric AML Trial (ELU001)

Not yet recruiting
  • CBFA2T3-GLIS2-positive Acute Myeloid Leukemia
  • +3 more
  • (no location specified)
Nov 14, 2022

Male Infertility, Azoospermia Trial in Seattle (13-cis retinoic acid)

Completed
Has Results
  • Male Infertility, Azoospermia
  • 13-cis retinoic acid
  • Seattle, Washington
    University of Washington Medical Center
Sep 27, 2021

Male Infertility, Klinefelter's Syndrome, Y-chromosome Microdeletions Trial in Seattle (13-cis retinoic acid, Calcitriol)

Completed
Has Results
  • Male Infertility
  • +2 more
  • Seattle, Washington
    University of Washington Medical Center
Jul 29, 2021

Depressive Disorder, Major, Bipolar Disorder, Post Traumatic Stress Disorder Trial in New Haven (Ketamine, Perampanel, Placebo)

Recruiting
  • Depressive Disorder, Major
  • +2 more
  • New Haven, Connecticut
    Yale University
Aug 8, 2022

Scalp Psoriasis Trial in Karachi (Tazarotene 0.045% Topical Application Lotion [ARAZLO])

Completed
  • Scalp Psoriasis
  • Tazarotene 0.045% Topical Application Lotion [ARAZLO]
  • Karachi, Sindh, Pakistan
    JPMC
Aug 28, 2023

Tuberculosis Trial in Cairo, Riyadh (13 cis retinoic acid, Minocycline, Chicroic Acid and Vitamin D for (MDR-TB), 9 cis retinoic

Not yet recruiting
  • Tuberculosis
  • 13 cis retinoic acid, Minocycline, Chicroic Acid and Vitamin D for (MDR-TB)
  • +5 more
  • Cairo, Kafr El-sheikh, Egypt
  • +1 more
Oct 11, 2021

COVID19 Trial in Cairo (Drug Isotretinoin (13 cis retinoic acid ) capsules+standard treatment, Isotretinoin(Aerosolized 13 cis

Not yet recruiting
  • COVID19
  • Drug Isotretinoin (13 cis retinoic acid ) capsules+standard treatment
  • +4 more
  • Cairo, Kafr El-sheikh, Egypt
  • +1 more
Jul 29, 2021

Covid19 Vaccine Trial (drug, combination product, biological)

Not yet recruiting
  • Covid19 Vaccine
  • Oral 13 cis retinoic acid
  • +4 more
  • (no location specified)
May 28, 2021

HR+/HER2- Advanced Breast Cancer, Targeted Therapy Trial in Beijing (Everolimus, Chidamide, Endocrine therapy)

Recruiting
  • HR+/HER2- Advanced Breast Cancer
  • Targeted Therapy
  • Beijing, Beijing, China
    National Cancer Center/National Clinical Research Center for Can
Aug 1, 2023

Depressive Disorder, MDD, Bipolar Disorder Trial in West Haven (Perampanel 6 MG, Ketamine, Placebo)

Not yet recruiting
  • Depressive Disorder
  • +4 more
  • Perampanel 6 MG
  • +2 more
  • West Haven, Connecticut
    VA Connecticut Healthcare System
Mar 14, 2023

NETs: Protection or Harm in Neonatal Inflammation or Infection

Recruiting
  • Necrotizing Enterocolitis (NEC)
    • Salt Lake City, Utah
      University of Utah
    Mar 31, 2022

    Multiple Myeloma Trial in Hackensack (Daratumumab, Pomalidomide, All-trans retinoic acid)

    Recruiting
    • Multiple Myeloma
    • Hackensack, New Jersey
      John Theurer Cancer Center
    Jun 10, 2022

    Hormone Receptor-Positive HER2-Negative Advanced Breast Cancer Trial in Singapore (Oral lenvatinib + Intravenous (IV)

    Not yet recruiting
    • Hormone Receptor-Positive HER2-Negative Advanced Breast Cancer
    • Oral lenvatinib + Intravenous (IV) pembrolizumab + Oral letrozole
    • Singapore, Singapore
      National Cancer Centre Singapore
    Oct 13, 2022

    MDS Trial (Roxadustat in combination with retinoic acid)

    Not yet recruiting
    • Myelodysplastic Syndromes
    • Roxadustat in combination with retinoic acid
    • (no location specified)
    Aug 26, 2023

    Melanoma Trial in Aurora (VESANOID, Ipilimumab)

    Active, not recruiting
    Has Results
    • Melanoma
    • Aurora, Colorado
      University of Colorado Hospital
    Sep 7, 2022

    Childhood Acute Promyelocytic Leukemia (M3), Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies Trial in

    Active, not recruiting
    Has Results
    • Childhood Acute Promyelocytic Leukemia (M3)
    • Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies
    • arsenic trioxide
    • +7 more
    • Birmingham, Alabama
    • +110 more
    Mar 23, 2022

    ALDH1A1 Expression in Invasive Mammary Carcinoma

    Enrolling by invitation
    • Breast Cancer
      • Sohag, Egypt
        Faculty of Medicine
      Nov 12, 2023

      Metastatic Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial in

      Recruiting
      • Metastatic Lung Non-Small Cell Carcinoma
      • +4 more
      • Columbus, Ohio
        Ohio State University Comprehensive Cancer Center
      Apr 27, 2022